Overview
Hydroxychloroquine is a medication that has received significant attention due to the COVID-19 pandemic. It is a drug that has been traditionally used for the treatment of malaria, autoimmune diseases like Rheumatoid Arthritis and Lupus, and several other ailments. Due to its potential role in preventing the symptoms of COVID-19, Hydroxychloroquine has become an important medication in the fight against the ongoing pandemic. The drug has been found to inhibit the replication of coronavirus, making it a potential candidate for the treatment of COVID-19. Several clinical studies have been conducted to test the efficacy and safety of Hydroxychloroquine in the treatment of COVID-19. While some studies suggest that it may be beneficial in reducing the progression of the disease, others have reported no significant benefits. It is important to note that Hydroxychloroquine should only be used in accordance with the recommendation of a healthcare provider. Moreover, it has been associated with several side effects, including gastrointestinal discomfort, skin rashes, and blurred vision. In conclusion, Hydroxychloroquine has emerged as an important medication in the fight against the COVID-19 pandemic. While it has been shown to have some efficacy in reducing the progression of the disease, further studies are required to determine its safety and efficacy as a COVID-19 treatment.
Research published in this journal
4 peer-reviewed articles, ranked by relevance. Each links to its DOI.
SARS-Cov-2 Viral Kinetics in Mild COVID-19 Patients Treated with Chloroquine Regimens or Standard of Care
Can Vitamin D Positively Impact COVID-19 Risk and Severity Among Older Adults: A Review of the Evidence
Medical Concepts with Clinical-Epidemiological Implications that have to be Re-Assessed Since the Coronavirus Disease 2019 (Covid-19) Pandemic
How this research is being cited
The 4 articles above have been cited 4 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2025 · Inflammopharmacology
-
2025 · Inflammopharmacology
-
2021 · International Journal of Community Medicine and Public Health
-
2020 · Epidemiology International Journal
A sample of recent works citing this journal's research on Hydroxychloroquine, linking to each citing work.